Clinical trial • Phase III • Other
Clinical trial in Healthy volunteer
Phase III trial for Healthy volunteer. None/Not specified-controlled. 240 participants.
Overview
- Trial Therapeutic Area
- Other
- Trial Disease
- Healthy volunteer
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 13-08-2024
- First CTIS Authorization Date
- 02-09-2024
Trial design
None/Not specified-controlled Phase III trial across 1 site in Denmark.
- Comparator
- None/Not specified
- Target Sample Size
- 240
Eligibility
Recruits 240 Vulnerable population selected; no details on consent or assent handling provided..
- Vulnerable Population
- Vulnerable population selected; no details on consent or assent handling provided.
Recruitment
- Planned Sample Size
- 240
- Recruitment Window Months
- 179
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 240
Denmark
- Earliest CTIS Part Ii Submission Date
- 21-08-2024
- Latest Decision Or Authorization Date
- 02-09-2024
- Processing Time Days
- 12
- Number Of Sites
- 1
- Number Of Participants
- 240
Sites
- Site Name
- Rigshospitalet
- Department Name
- Neurobiology Research Unit
- Contact Person Name
- Gitte Moos Knudsen
- Contact Person Email
- gmk@nru.dk
Sponsor
Primary sponsor
- Full Name
- Rigshospitalet
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- Denmark
Related trials
Other published trials that may interest you.